ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2500 Growth Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.79 USD | +1.04% | -0.29% | +0.15% |
Mar. 13 | Stifel Adjusts Price Target on ClearPoint Neuro to $9 From $8, Maintains Buy Rating | MT |
Mar. 12 | ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.15% | 181M | |
+9.14% | 221B | |
+8.02% | 184B | |
+18.09% | 142B | |
+18.65% | 101B | |
+7.83% | 68.07B | |
+24.93% | 57.27B | |
-3.69% | 47.42B | |
+5.21% | 43.19B | |
+15.04% | 28.84B |
- Stock
- Equities
- Stock ClearPoint Neuro, Inc. - Nasdaq
- News ClearPoint Neuro, Inc.
- ClearPoint Neuro, Inc.(NasdaqCM: CLPT) dropped from Russell 2500 Growth Index